2022-2030 Global and Regional Endocannabinoid System Targeted Therapeutics Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report Standard Version

Table Of Contents

Chapter 1 Industry Overview

1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2030)
1.4.2 East Asia Market States and Outlook (2022-2030)
1.4.3 Europe Market States and Outlook (2022-2030)
1.4.4 South Asia Market States and Outlook (2022-2030)
1.4.5 Southeast Asia Market States and Outlook (2022-2030)
1.4.6 Middle East Market States and Outlook (2022-2030)
1.4.7 Africa Market States and Outlook (2022-2030)
1.4.8 Oceania Market States and Outlook (2022-2030)
1.4.9 South America Market States and Outlook (2022-2030)
1.5 Global Endocannabinoid System Targeted Therapeutics Market Size Analysis from 2022 to 2027
1.5.1 Global Endocannabinoid System Targeted Therapeutics Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Endocannabinoid System Targeted Therapeutics Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Endocannabinoid System Targeted Therapeutics Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Endocannabinoid System Targeted Therapeutics Industry Impact
Chapter 2 Global Endocannabinoid System Targeted Therapeutics Competition by Types, Applications, and Top Regions and Countries
2.1 Global Endocannabinoid System Targeted Therapeutics (Volume and Value) by Type
2.1.1 Global Endocannabinoid System Targeted Therapeutics Consumption and Market Share by Type (2017-2022)
2.1.2 Global Endocannabinoid System Targeted Therapeutics Revenue and Market Share by Type (2017-2022)
2.2 Global Endocannabinoid System Targeted Therapeutics (Volume and Value) by Application
2.2.1 Global Endocannabinoid System Targeted Therapeutics Consumption and Market Share by Application (2017-2022)
2.2.2 Global Endocannabinoid System Targeted Therapeutics Revenue and Market Share by Application (2017-2022)
2.3 Global Endocannabinoid System Targeted Therapeutics (Volume and Value) by Regions
2.3.1 Global Endocannabinoid System Targeted Therapeutics Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Endocannabinoid System Targeted Therapeutics Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Endocannabinoid System Targeted Therapeutics Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Endocannabinoid System Targeted Therapeutics Consumption by Regions (2017-2022)
4.2 North America Endocannabinoid System Targeted Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Endocannabinoid System Targeted Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Endocannabinoid System Targeted Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Endocannabinoid System Targeted Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Endocannabinoid System Targeted Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Endocannabinoid System Targeted Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Endocannabinoid System Targeted Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Endocannabinoid System Targeted Therapeutics Sales, Consumption, Export, Import (2017-2022)
4.10 South America Endocannabinoid System Targeted Therapeutics Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Endocannabinoid System Targeted Therapeutics Market Analysis
5.1 North America Endocannabinoid System Targeted Therapeutics Consumption and Value Analysis
5.1.1 North America Endocannabinoid System Targeted Therapeutics Market Under COVID-19
5.2 North America Endocannabinoid System Targeted Therapeutics Consumption Volume by Types
5.3 North America Endocannabinoid System Targeted Therapeutics Consumption Structure by Application
5.4 North America Endocannabinoid System Targeted Therapeutics Consumption by Top Countries
5.4.1 United States Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
5.4.2 Canada Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
5.4.3 Mexico Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
Chapter 6 East Asia Endocannabinoid System Targeted Therapeutics Market Analysis
6.1 East Asia Endocannabinoid System Targeted Therapeutics Consumption and Value Analysis
6.1.1 East Asia Endocannabinoid System Targeted Therapeutics Market Under COVID-19
6.2 East Asia Endocannabinoid System Targeted Therapeutics Consumption Volume by Types
6.3 East Asia Endocannabinoid System Targeted Therapeutics Consumption Structure by Application
6.4 East Asia Endocannabinoid System Targeted Therapeutics Consumption by Top Countries
6.4.1 China Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
6.4.2 Japan Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
6.4.3 South Korea Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
Chapter 7 Europe Endocannabinoid System Targeted Therapeutics Market Analysis
7.1 Europe Endocannabinoid System Targeted Therapeutics Consumption and Value Analysis
7.1.1 Europe Endocannabinoid System Targeted Therapeutics Market Under COVID-19
7.2 Europe Endocannabinoid System Targeted Therapeutics Consumption Volume by Types
7.3 Europe Endocannabinoid System Targeted Therapeutics Consumption Structure by Application
7.4 Europe Endocannabinoid System Targeted Therapeutics Consumption by Top Countries
7.4.1 Germany Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
7.4.2 UK Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
7.4.3 France Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
7.4.4 Italy Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
7.4.5 Russia Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
7.4.6 Spain Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
7.4.7 Netherlands Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
7.4.8 Switzerland Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
7.4.9 Poland Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
Chapter 8 South Asia Endocannabinoid System Targeted Therapeutics Market Analysis
8.1 South Asia Endocannabinoid System Targeted Therapeutics Consumption and Value Analysis
8.1.1 South Asia Endocannabinoid System Targeted Therapeutics Market Under COVID-19
8.2 South Asia Endocannabinoid System Targeted Therapeutics Consumption Volume by Types
8.3 South Asia Endocannabinoid System Targeted Therapeutics Consumption Structure by Application
8.4 South Asia Endocannabinoid System Targeted Therapeutics Consumption by Top Countries
8.4.1 India Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
8.4.2 Pakistan Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Endocannabinoid System Targeted Therapeutics Market Analysis
9.1 Southeast Asia Endocannabinoid System Targeted Therapeutics Consumption and Value Analysis
9.1.1 Southeast Asia Endocannabinoid System Targeted Therapeutics Market Under COVID-19
9.2 Southeast Asia Endocannabinoid System Targeted Therapeutics Consumption Volume by Types
9.3 Southeast Asia Endocannabinoid System Targeted Therapeutics Consumption Structure by Application
9.4 Southeast Asia Endocannabinoid System Targeted Therapeutics Consumption by Top Countries
9.4.1 Indonesia Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
9.4.2 Thailand Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
9.4.3 Singapore Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
9.4.4 Malaysia Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
9.4.5 Philippines Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
9.4.6 Vietnam Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
9.4.7 Myanmar Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
Chapter 10 Middle East Endocannabinoid System Targeted Therapeutics Market Analysis
10.1 Middle East Endocannabinoid System Targeted Therapeutics Consumption and Value Analysis
10.1.1 Middle East Endocannabinoid System Targeted Therapeutics Market Under COVID-19
10.2 Middle East Endocannabinoid System Targeted Therapeutics Consumption Volume by Types
10.3 Middle East Endocannabinoid System Targeted Therapeutics Consumption Structure by Application
10.4 Middle East Endocannabinoid System Targeted Therapeutics Consumption by Top Countries
10.4.1 Turkey Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
10.4.3 Iran Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
10.4.5 Israel Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
10.4.6 Iraq Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
10.4.7 Qatar Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
10.4.8 Kuwait Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
10.4.9 Oman Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
Chapter 11 Africa Endocannabinoid System Targeted Therapeutics Market Analysis
11.1 Africa Endocannabinoid System Targeted Therapeutics Consumption and Value Analysis
11.1.1 Africa Endocannabinoid System Targeted Therapeutics Market Under COVID-19
11.2 Africa Endocannabinoid System Targeted Therapeutics Consumption Volume by Types
11.3 Africa Endocannabinoid System Targeted Therapeutics Consumption Structure by Application
11.4 Africa Endocannabinoid System Targeted Therapeutics Consumption by Top Countries
11.4.1 Nigeria Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
11.4.2 South Africa Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
11.4.3 Egypt Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
11.4.4 Algeria Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
11.4.5 Morocco Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
Chapter 12 Oceania Endocannabinoid System Targeted Therapeutics Market Analysis
12.1 Oceania Endocannabinoid System Targeted Therapeutics Consumption and Value Analysis
12.2 Oceania Endocannabinoid System Targeted Therapeutics Consumption Volume by Types
12.3 Oceania Endocannabinoid System Targeted Therapeutics Consumption Structure by Application
12.4 Oceania Endocannabinoid System Targeted Therapeutics Consumption by Top Countries
12.4.1 Australia Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
12.4.2 New Zealand Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
Chapter 13 South America Endocannabinoid System Targeted Therapeutics Market Analysis
13.1 South America Endocannabinoid System Targeted Therapeutics Consumption and Value Analysis
13.1.1 South America Endocannabinoid System Targeted Therapeutics Market Under COVID-19
13.2 South America Endocannabinoid System Targeted Therapeutics Consumption Volume by Types
13.3 South America Endocannabinoid System Targeted Therapeutics Consumption Structure by Application
13.4 South America Endocannabinoid System Targeted Therapeutics Consumption Volume by Major Countries
13.4.1 Brazil Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
13.4.2 Argentina Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
13.4.3 Columbia Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
13.4.4 Chile Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
13.4.5 Venezuela Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
13.4.6 Peru Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
13.4.8 Ecuador Endocannabinoid System Targeted Therapeutics Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Endocannabinoid System Targeted Therapeutics Business
14.1 GW Pharmaceuticals
14.1.1 GW Pharmaceuticals Company Profile
14.1.2 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Specification
14.1.3 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 MAKScientific
14.2.1 MAKScientific Company Profile
14.2.2 MAKScientific Endocannabinoid System Targeted Therapeutics Product Specification
14.2.3 MAKScientific Endocannabinoid System Targeted Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Corbus Pharmaceuticals
14.3.1 Corbus Pharmaceuticals Company Profile
14.3.2 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Specification
14.3.3 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Tilray
14.4.1 Tilray Company Profile
14.4.2 Tilray Endocannabinoid System Targeted Therapeutics Product Specification
14.4.3 Tilray Endocannabinoid System Targeted Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Pure Green
14.5.1 Pure Green Company Profile
14.5.2 Pure Green Endocannabinoid System Targeted Therapeutics Product Specification
14.5.3 Pure Green Endocannabinoid System Targeted Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Avicanna
14.6.1 Avicanna Company Profile
14.6.2 Avicanna Endocannabinoid System Targeted Therapeutics Product Specification
14.6.3 Avicanna Endocannabinoid System Targeted Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 GB Sciences
14.7.1 GB Sciences Company Profile
14.7.2 GB Sciences Endocannabinoid System Targeted Therapeutics Product Specification
14.7.3 GB Sciences Endocannabinoid System Targeted Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Botanix Pharmaceuticals
14.8.1 Botanix Pharmaceuticals Company Profile
14.8.2 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Specification
14.8.3 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Therapix Biosciences
14.9.1 Therapix Biosciences Company Profile
14.9.2 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product Specification
14.9.3 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Zelira Therapeutics
14.10.1 Zelira Therapeutics Company Profile
14.10.2 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product Specification
14.10.3 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Endocannabinoid System Targeted Therapeutics Market Forecast (2022-2030)
15.1 Global Endocannabinoid System Targeted Therapeutics Consumption Volume, Revenue and Price Forecast (2022-2030)
15.1.1 Global Endocannabinoid System Targeted Therapeutics Consumption Volume and Growth Rate Forecast (2022-2030)
15.1.2 Global Endocannabinoid System Targeted Therapeutics Value and Growth Rate Forecast (2022-2030)
15.2 Global Endocannabinoid System Targeted Therapeutics Consumption Volume, Value and Growth Rate Forecast by Region (2022-2030)
15.2.1 Global Endocannabinoid System Targeted Therapeutics Consumption Volume and Growth Rate Forecast by Regions (2022-2030)
15.2.2 Global Endocannabinoid System Targeted Therapeutics Value and Growth Rate Forecast by Regions (2022-2030)
15.2.3 North America Endocannabinoid System Targeted Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.4 East Asia Endocannabinoid System Targeted Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.5 Europe Endocannabinoid System Targeted Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.6 South Asia Endocannabinoid System Targeted Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.7 Southeast Asia Endocannabinoid System Targeted Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.8 Middle East Endocannabinoid System Targeted Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.9 Africa Endocannabinoid System Targeted Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.10 Oceania Endocannabinoid System Targeted Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.2.11 South America Endocannabinoid System Targeted Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2022-2030)
15.3 Global Endocannabinoid System Targeted Therapeutics Consumption Volume, Revenue and Price Forecast by Type (2022-2030)
15.3.1 Global Endocannabinoid System Targeted Therapeutics Consumption Forecast by Type (2022-2030)
15.3.2 Global Endocannabinoid System Targeted Therapeutics Revenue Forecast by Type (2022-2030)
15.3.3 Global Endocannabinoid System Targeted Therapeutics Price Forecast by Type (2022-2030)
15.4 Global Endocannabinoid System Targeted Therapeutics Consumption Volume Forecast by Application (2022-2030)
15.5 Endocannabinoid System Targeted Therapeutics Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology